Compound ID | 2851
Class: Small molecule antibacterial agent
| Agent Type: | Synthetic; Small molecule; Direct acting; Antivirulence; |
| Spectrum of activity: | Antimycobacterial |
| Mechanism of action: | Cytochrome bc1 inhibitor |
| Target Pathogen: | Active against Mycobacterium tuberculosis |
| Propensity to select resistant mutants: | Yes, at 3.33x10^-9 mutation frequency at 5xMIC |
| Description: | Synthetic compound; thiazole; no macrophage cytotoxicity at 200 uM (highest concentration tested) |
| Institute where first reported: | German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany |
| Year first mentioned: | 2023 |
| Development status: | Experimental |
| External links: | |
| Citation: | https://journals.asm.org/doi/10.1128/aac.00251-23 |